Audit Vendors Periodically to Ensure GMP Compliance in the Supply Chain

Conduct Periodic Vendor Audits to Safeguard GMP Supply Chain Integrity

Remember: GMP requires periodic audits of vendors to ensure they meet quality, safety, and regulatory standards for pharmaceutical manufacturing inputs.

Why This Matters in GMP

Raw materials, packaging components, and critical services form the backbone of pharmaceutical production. If suppliers do not comply with GMP standards, they can introduce serious risks—such as contamination, batch failure, or regulatory non-compliance. Periodic vendor audits allow manufacturers to evaluate suppliers’ quality systems, facility conditions, and adherence to agreed specifications. These audits also identify areas for improvement, detect early signs of deviation, and help maintain robust supply chain control. Failure to audit can result in undetected quality issues or compromised final product safety.

Also Read: Never Rely on Electronic Signatures Without System Validation

Regulatory and Compliance Implications

FDA 21 CFR Part 211.84 requires suppliers to be qualified, and materials to be tested or verified. EU GMP Chapter 7 emphasizes the need for written quality agreements and supplier audits based on risk. WHO GMP and Schedule M also mandate supplier qualification through on-site assessments, questionnaires, and performance monitoring. Regulatory bodies expect to see vendor qualification logs, audit reports, follow-up CAPAs, and requalification timelines. Missing or outdated audits are treated

as significant gaps in quality oversight.

Implementation Best Practices

Classify vendors based on material criticality and audit them at intervals defined by risk category (e.g., annually, biennially).
Use comprehensive audit checklists covering GMP compliance, documentation, equipment, training, and deviation handling.
Document findings with evidence and implement CAPAs for any non-conformities.
Maintain a vendor rating system linked to audit scores and complaint records.
Update quality agreements to reflect the latest audit scope and commitments.

Also Read: Never Permit Chemical Reuse in GMP Without Full Requalification

Regulatory References

FDA 21 CFR Part 211.84 – Testing and Approval of Components
EU GMP Chapter 7 – Outsourced Activities and Supplier Audit
WHO GMP – Supplier Qualification Guidelines
Schedule M – Vendor Assessment and Documentation